2人のインド国籍の人物が国際的な偽造Ozempicの計画で起訴された
連邦大陪審團は、Ozempicに関連する偽造処方薬の配布計画に巻き込まれたとされる陰謀および密輸の罪でSwapnadip Roy氏とVicky Ramancha氏を起訴しました。
なぜ重要か. 規制当局は偽造品製造者に対して行動を取っており、これにより医薬品業界と患者の安全に影響を与える可能性があります。
01
根拠
- UUS Department of Justice press規制当局2026-09-29 20:00
A federal grand jury in the Middle District of Florida charged two individuals, Swapnadip Roy, 33, and Vicky Ramancha, 37, both Indian nationals, with conspiracy and smuggling related to an alleged transnational counterfeit prescription drug distribution scheme.
- UUS Department of Justice press規制当局2026-09-29 20:00
A federal grand jury in the Middle District of Florida charged two individuals, Swapnadip Roy, 33, and Vicky Ramancha, 37, both Indian nationals, with conspiracy and smuggling related to an alleged transnational counterfeit prescription drug distribution scheme. The indictment alleges that Roy, Ramancha, and their co-conspirators sold counterfeit Ozempic to distributors in the United States at de…
- UUS Department of Justice press規制当局2026-09-29 20:00
Roy and Ramancha are charged with one count of conspiracy to commit smuggling and to defraud the United States, three counts of smuggling, and two counts of selling counterfeit drugs and holding counterfeit drugs for sale.